Aurisco Pharmaceutical Co Ltd (605116) — Financial Flexibility Index
Aurisco Pharmaceutical Co Ltd (605116) has a Financial Flexibility Index of 0.56x as of December 2024. Free cash flow of CN¥872.68 Million (operating CF CN¥332.41 Million minus capex CN¥540.28 Million) represents 1% of total liabilities (CN¥1.55 Billion). Check 605116 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aurisco Pharmaceutical Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Aurisco Pharmaceutical Co Ltd across 8 annual periods. See 605116 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aurisco Pharmaceutical Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Aurisco Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 605116 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.56x | CN¥872.68 Million | CN¥332.41 Million | CN¥1.55 Billion | ▼ -50.4% |
| 2023 | 1.14x | CN¥691.08 Million | CN¥385.61 Million | CN¥607.03 Million | ▲ +3.7% |
| 2022 | 1.10x | CN¥382.63 Million | CN¥166.41 Million | CN¥348.68 Million | ▼ -48.2% |
| 2021 | 2.12x | CN¥452.19 Million | CN¥201.57 Million | CN¥213.44 Million | ▼ -16.0% |
| 2020 | 2.52x | CN¥373.28 Million | CN¥214.48 Million | CN¥147.98 Million | ▲ +22.9% |
| 2019 | 2.05x | CN¥252.38 Million | CN¥179.90 Million | CN¥122.96 Million | ▲ +34.0% |
| 2018 | 1.53x | CN¥203.91 Million | CN¥109.77 Million | CN¥133.16 Million | ▼ -9.7% |
| 2017 | 1.70x | CN¥224.51 Million | CN¥117.91 Million | CN¥132.44 Million | — |